Retrospective Analysis of Intracranial Hemorrhages in the COVID-19 Pandemic.
Turk Neurosurg
; 31(5): 763-770, 2021.
Article
in English
| MEDLINE | ID: covidwho-1512942
ABSTRACT
AIM:
To identify the characteristics of patients admitted to the emergency department with intracranial hemorrhages in the era of the COVID-19 pandemic. MATERIAL ANDMETHODS:
Seventy-eight patients with spontaneous intracranial bleeding who were admitted to emergency departments and treated in neurosurgery clinics between March 11, 2020, and September 11, 2020, were included in the study.RESULTS:
The most frequent symptom was the loss of consciousness (32.1%), followed by headache (15.4%), syncope (10.3%), motor loss (9%), and seizures (9%). Antiaggregant and anticoagulant drug use were detected in 37.2% of the patients. Intraparenchymal hematoma was the most common type of intracranial hemorrhage (59%). Viral pneumonia was detected in 52.6% of the patients in thorax CTs. Surgical treatment was applied to 23.1% of the patients. There was no significant difference between patients with pneumonia and patients without pneumonia in the treatment modalities or 30-day mortality.CONCLUSION:
In this study, we found that low Glasgow Coma Scores affected mortality and that mechanical ventilation needs are higher in ICH patients with COVID-19. Nevertheless, the treatment differences may not have affected the outcomes.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pandemics
/
COVID-19
Type of study:
Observational study
/
Prognostic study
Limits:
Humans
Language:
English
Journal:
Turk Neurosurg
Journal subject:
Neurosurgery
Year:
2021
Document Type:
Article
Affiliation country:
1019-5149.Jtn.33824-21.1
Similar
MEDLINE
...
LILACS
LIS